Barclays
CLLS

Barclays’s Cellectis CLLS Stock Holding History

Barclays’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710 Buy
+224
New +$859 ﹤0.01% 4920
2023
Q4 		– Sell
-28
Closed -$44 – 5236
2023
Q3 		$44 Hold
28
– – ﹤0.01% 4558
2023
Q2 		$55 Hold
28
– – ﹤0.01% 4456
2023
Q1 		$54 Hold
28
– – ﹤0.01% 5013
2022
Q4 		$59 Sell
28
-622
-96% -$1.41K ﹤0.01% 5209
2022
Q3 		$1K Buy
+650
New +$1.97K ﹤0.01% 4679
2022
Q1 		– Sell
-2,324
Closed -$19K – 5018
2021
Q4 		$19K Sell
2,324
-41,264
-95% -$406K ﹤0.01% 3954
2021
Q3 		$549K Sell
43,588
-19,801
-31% -$274K ﹤0.01% 3141
2021
Q2 		$980K Buy
63,389
+40,173
+173% +$675K ﹤0.01% 2670
2021
Q1 		$469K Buy
23,216
+18,688
+413% +$462K ﹤0.01% 3215
2020
Q4 		$123K Buy
4,528
+4,043
+834% +$90.7K ﹤0.01% 4034
2020
Q3 		$9K Buy
+485
New +$8.61K ﹤0.01% 5023
2020
Q1 		– Sell
-71
Closed -$1K – 6164
2019
Q4 		$1K Sell
71
-290
-80% -$3.87K ﹤0.01% 6270
2019
Q3 		$4K Buy
361
+260
+257% +$3.5K ﹤0.01% 6471
2019
Q2 		$2K Sell
101
-1,131
-92% -$20.2K ﹤0.01% 6791
2019
Q1 		$23K Buy
1,232
+1,145
+1,316% +$20.3K ﹤0.01% 6292
2018
Q4 		$1K Buy
87
+1
+1% +$23 ﹤0.01% 6783
2018
Q3 		$2K Sell
86
-4,760
-98% -$137K ﹤0.01% 6929
2018
Q2 		$137K Sell
4,846
-6
-0.1% -$179 ﹤0.01% 5035
2018
Q1 		$152K Buy
4,852
+52
+1% +$1.64K ﹤0.01% 5066
2017
Q4 		$140K Sell
4,800
-10,300
-68% -$281K ﹤0.01% 4976
2017
Q3 		$430K Buy
+15,100
New +$391K ﹤0.01% 3767
2015
Q2 		– Sell
-90
Closed -$3K – 7028
2015
Q1 		$3K Buy
+90
New +$3.27K ﹤0.01% 6757

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Barclays's CLLS Position: Q1 2026 in Review

Barclays opened a new position in Cellectis (CLLS) in Q1 2026: 224 shares worth $710. The stake represents ﹤0.01% of the portfolio and ranks #4920 among its holdings. This is a return to the name: Barclays previously reported a position in CLLS as recently as Q3 2023.

Barclays first reported a position in CLLS in Q1 2015 and has held it in 23 quarters since. The position peaked at $980K in Q2 2021. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Barclays held 224 shares of Cellectis worth $710 as of Q1 2026.
  • Cellectis was a new Barclays position in Q1 2026.
  • Cellectis made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4920 holding.
  • Barclays first reported a position in Cellectis in Q1 2015 and has held it in 23 quarters since.
  • Barclays's Cellectis position peaked at $980K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.